SavedAdd your journal

Journals / Nöropsikiyatri Arşivi / 2019 / Cilt: 56 - Sayı: 2

Loss of Sight Caused by Ocular Self-Mutilative Behaviour: A Case of Malignant Tourette Syndrome

Oküler Kendini Yaralama Davranışı Sonucu Gelişen Görme Kaybı: Bir Malign Tourette Sendromu Olgusu

İbrahim Fuat AKGÜL
Hakan KARAŞ
İshak SAYGILI
Haluk USTA
Pages
162–164
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we present an adult case of Tourette Syndrome with vision loss as a result of recurrent and severe ocular self-mutilative tics.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tourette’s Syndrome is developmental neuropsychiatric disorder characterized by stereotypic, non-rhythmic multiple motor and/or vocal tics.
📊
Key Findings & Data:In rare cases, severe tics which can be life-threatening or selfmutilating may be observed in Tourette Syndrome.
💡
Conclusion & Impact:In this report, we present an adult case of Tourette Syndrome with vision loss as a result of recurrent and severe ocular self-mutilative tics.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tourette’s Syndrome is developmental neuropsychiatric disorder characterized by stereotypic, non-rhythmic multiple motor and/or vocal tics. In rare cases, severe tics which can be life-threatening or selfmutilating may be observed in Tourette Syndrome. These types of cases that involve severe self-injurious behavior are called malignant Tourette’s Syndrome. In this report, we present an adult case of Tourette Syndrome with vision loss as a result of recurrent and severe ocular self-mutilative tics.

Özet

Tourette Sendromu genellikle stereotipik, ritmik olmayan, çoklu motor veya vokal tiklerle karakterize gelişimsel bir nöropsikiyatrik bozukluktur. Nadir durumlarda, Tourette Sendromunda yaşamı tehdit edici veya kendini sakatlayacak derecede ağır tikler gözlenebilir. Bu tür şiddetli kendini yaralama davranışı içeren olgular malign Tourette Sendromu olarak adlandırılmaktadır. Bu yazıda tekrarlayıcı ve şiddetli oküler kendine zarar verme tikleri sonucunda görme kaybı gelişen erişkin bir Tourette Sendromu olgusu sunulacaktır.

🔖

Cite This Article

AKGÜL, İ. F., KARAŞ, H., SAYGILI, İ., USTA, H. (2019). Loss of Sight Caused by Ocular Self-Mutilative Behaviour: A Case of Malignant Tourette Syndrome. Nöropsikiyatri Arşivi, Cilt: 56 - Sayı: 2, 162–164. https://ajindex.com/articles/292194

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Gravino G. Gilles de la Tourette syndrome. Ann Clin Psychiatry 2013;25:297– 306
  2. Jankovic J, Gelineau-Kattner R, Davidson A. Tourette’s syndrome in adults. Mov Disord 2010;25:2171–2175. [CrossRef] 3. Cheung MYC, Shahed J, Jankovic J. Malignant tourette syndrome. Mov Disord 2007;22:1743–1750. [CrossRef] 4. Robertson MM, Trimble M, Lees A. Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature. Psychol Med 1989;19:611–625. [CrossRef] 5. Thenganatt MA, Jankovic J. Recent advances in understanding and managing Tourette syndrome. F1000Res 2016;5. pii: F1000 Faculty Rev-152. [CrossRef] 6. Jankovic J. Tourette’s syndrome. N Engl J Med 2001;345:1184–1192. [CrossRef] 7. Adam OR, Ferrara JM, Jankovic J. Motor-phonic tic mimicking essential palatal myoclonus. Mov Disord 2009;24:2030–2032. [CrossRef] 8. Yaltho TC, Jankovic J, Lotze T. The association of Tourette syndrome and dopa-responsive dystonia. Mov Disord 2011;26:359–360. [CrossRef] 9. Kamaşak T, Cansu A. Tik Bozuklukları. Turkiye Klinikleri J Pediatr Sci 2017;13:121–129
  3. Mathews C, Waller J, Glidden D, Lowe T, Herrera L, Budman C, Erenberg G, Naarden A, Bruun RD, Freimer NB, Reus VI. Self injurious behaviour in Tourette syndrome: correlates with impulsivity and impulse control. J Neurol Neurosurg Psychiatry 2004;75:1149–1155. [CrossRef] 11. Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011;26:1149–1156. [CrossRef] 12. Mink JW. Basal ganglia dysfunction in Tourette’s syndrome: a new hypothesis. Pediatr Neurol 2001;25:190–198. [CrossRef] 13. Muellner J, Delmaire C, Valabrégue R, Schüpbach M, Mangin JF, Vidailhet M, Lehéricy S, hartmann A, Worbe Y. Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development. Mov Disord 2015;30:655–661. [CrossRef] 14. Zheng W, Li XB, Xiang YQ, Zhong BL, Chiu HF, Ungvari GS, Ng CH, Lok GKI, Xiang YT. Aripiprazole for Tourette’s syndrome: a systematic review and meta-analysis. Hum Psychopharm Clin 2016;31:11–18. [CrossRef] 15. Roessner V, Plessen KJ, Rothenberger A, Ludolph, A G, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra P, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part II. pharmacological treatment. Eur Child Adolesc Psychiatry 2011;20:173–196. [CrossRef] 16. Lim S, Rezai KA, Abrams GW, Eliott D. Self-induced, bilateral retinal detachment in Tourette syndrome. Arc